Compare Cronos Group Inc (CRON) vs Microsoft (MSFT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cronos Group Inc vs Microsoft — how do they compare? Cronos Group Inc trades at $3.22 (market cap $1.18B), while Microsoft trades at $534.79 (market cap $3.88T). The key difference: Microsoft is far larger — about 3288.1× Cronos Group Inc's market cap, and Microsoft pays a 0.75% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Microsoft for 142 Days on average.
| CRON | MSFT | |
|---|---|---|
Market Cap | $1.18B | $3.88T |
Volume | 968,037 | 19,593,392 |
Sector | Health | Technology |
52-Week High | $3.55 | $542.07 |
52-Week Low | $2.30 | $352.83 |
Typical Hold Time | 22 Days | 142 Days |
Enterprise Value | $387.62M | $3.86T |
Dividend Yield | — | 0.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.23, down 0.31% with a bearish technical signal. Recent earnings show volatility with Q2 2026 beating expectations ($0.09 vs $0.01) but Q4 2025 missing. Revenue grew from $118M (2024) to $147M (2025), though net income turned negative at -$9M. The company maintains strong liquidity with $827M cash and no debt, highlighted in recent investor day presentations.
Outlook is mixed: analyst consensus leans Hold (60%) with cautious optimism on international expansion and margin improvements. Key risks include sustained negative cash flow (-$67M in 2025) and competitive pressures. Upside hinges on execution of growth initiatives in Canada and Europe, with profitability projections for 2026.
Microsoft (MSFT) trades at $535.07, up 1.0% with strong bullish technical signals and consistent earnings beats. The company demonstrates robust fundamentals with 36.1% net margins, $281.7B revenue, and healthy cash flow generation. Recent analyst coverage shows 82% buy ratings with a $571.76 consensus target, while technical indicators suggest support at $517 and resistance at $530.
MSFT presents a compelling investment case with strong AI positioning and cloud growth, though elevated valuation metrics and competitive pressures warrant caution. The stock's current level near resistance suggests potential for consolidation before further upside, supported by institutional confidence and solid financial performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cronos Group Inc
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →About Microsoft
Microsoft Corporation develops, manufactures, licenses, sells, and supports software products. The Company offers operating system software, server application software, business and consumer applications software, software development tools, and Internet and intranet software. Microsoft also develops video game consoles and digital music entertainment devices.
Read more on MSFT →
